GENEVA, Sept. 8 -- CEVA ANIMAL HEALTH TECHNOLOGY (HANGZHOU) CO., LTD. (401 No. 23 Street, Hangzhou Economic and Technical Development ZoneHangzhou, Zhejiang 310018) filed a patent application (PCT/CN2025/079881) for "RECOMBINANT HVT AND USES THEREOF" on Feb 28, 2025. With publication no. WO/2025/180501, the details related to the patent application was published on Sep 04, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): SASAKI, Kenta (401 No. 23 Street, Hangzhou Economic and Technical Development ZoneHangzhou, Zhejiang 310018)
Abstract:
Provided are recombinant herpes viruses of Turkeys c...